- The MIPS program has been widely criticized for increasing the administrative burden on physicians. The quality measures and performance methodology have been criticized for failing to encourage meaningful improvements in value and for penalizing small physician practices and physicians that treat higher-risk patients. The Medicare Payment Advisory Commission has called for abolishing the MIPS program.
- Most physicians have not even had an opportunity to participate in an APM because of the small number and narrow focus of the APMs that have been implemented by CMS. Moreover, those APMs that have been implemented have had disappointing results in terms of savings. PTAC has received and reviewed more than 30 proposals for new types of physician-focused APMs and it has recommended that HHS implement or test more than a dozen of the proposals, but as of March 2019, none of PTAC’s recommendations had been implemented.
WHO SHOULD ATTEND
- Health Care Attorneys and In-house Counsel
- Chief Financial Officers
- Chief Innovation Officers
- Directors of Accountable Care
- Directors of Quality Management and Improvement
- Directors of Government Programs
- Directors of Medicare Programs
- Directors of Medicaid Programs
- Directors of Network Contracting
- Directors of Provider Relations
- Directors of Finance and Reimbursement
- Pharmaceutical Executives
- Pharmaceutical Consultants